Neuberger Berman Group
ONC

Neuberger Berman Group’s BeOne Medicines Ltd ONC Stock Holding History

Neuberger Berman Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
4,404
+154
+4% +$49.8K ﹤0.01% 1322
2025
Q4 		$1.29M Buy
4,250
+353
+9% +$116K ﹤0.01% 1323
2025
Q3 		$1.31M Buy
3,897
+241
+7% +$73.2K ﹤0.01% 1283
2025
Q2 		$884K Buy
+3,656
New +$897K ﹤0.01% 1394

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group's ONC Position: Q1 2026 in Review

Neuberger Berman Group increased its BeOne Medicines Ltd (ONC) stake by 3.6% in Q1 2026, buying an estimated $49.8K and bringing the position to 4,404 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Neuberger Berman Group first reported a position in ONC in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.31M in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Neuberger Berman Group held 4,404 shares of BeOne Medicines Ltd worth $1.29M as of Q1 2026.
  • Neuberger Berman Group bought 154 BeOne Medicines Ltd shares in Q1 2026, an estimated $49.8K.
  • BeOne Medicines Ltd made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1322 holding.
  • Neuberger Berman Group first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 4 quarters since.
  • Neuberger Berman Group's BeOne Medicines Ltd position peaked at $1.31M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.